Ki Tua Fund invests in Fermeate to unlock next-generation control of microbial fermentation

The company has raised $2M in their Series Seed round from investors such as Newfund Capital, SOSV and Ajinomoto Group Ventures.

Fermeate’s platform uses light to dynamically regulate cellular processes, enabling more precise control over how microbes produce proteins and other ingredients. This approach has potential applications across food, ingredients and industrial biotechnology, where the platform aims to address key bottlenecks in scaling fermentation-based production by improving titers and yields.

Advances in cellular technologies and precision fermentation are creating new pathways to produce high-value ingredients, including dairy ingredients, and expand into emerging markets. This investment reflects The Ki Tua Fund’s focus on enabling technologies that support the evolution of industrial biotechnology and broaden the application of precision fermentation.

Ki Tua Fund Chief Science Officer, Jeremy Hill, notes the importance of backing innovative solutions in the rapidly developing cellular bioprocessing sector.

Visit www.fermeate.com to learn more.